Table 2.
Cross-validation performance of two glioma classification tasks.
Cell Size | Glioma detection | Glioma grading | ||||||
---|---|---|---|---|---|---|---|---|
ACC (SD) | SEN (SD) | SPE (SD) | AUC (SD) | ACC (SD) | SEN (SD) | SPE (SD) | AUC (SD) | |
10 | 74.9% (2.8) | 92.1% (2.1) | 51.6% (4.9) | 0.832 (0.012) | 71.2% (1.8) | 81.6% (1.5) | 58.0% (3.2) | 0.781 (0.017) |
11 | 73.4% (1.5) | 85.3% (2.6) | 52.7% (3.7) | 0.832 (0.015) | 71.0% (2.6) | 80.6% (2.9) | 58.9% (2.7) | 0.697 (0.013) |
12 | 80.4% (2.8) | 88.6% (2.4) | 66.0% (5.5) | 0.891 (0.011) | 66.8% (1.7) | 74.1% (2.7) | 57.1% (2.2) | 0.718 (0.024) |
13 | 72.4% (1.3) | 82.2% (1.3) | 55.2% (4.1) | 0.791 (0.017) | 70.7% (1.3) | 80.6% (2.6) | 57.9% (3.2) | 0.741 (0.015) |
14 | 72.5% (2.5) | 79.6% (2.3) | 59.8% (5.1) | 0.821 (0.021) | 74.8% (2.4) | 82.9% (3.9) | 64.1% (1.9) | 0.776 (0.015) |
15 | 73.0% (2.7) | 81.1% (2.6) | 58.6% (6.1) | 0.838 (0.019) | 74.3% (2.9) | 79.7% (2.6) | 67.6% (4.8) | 0.771 (0.022) |
16 | 82.8% (1.9) | 87.8% (2.6) | 73.9% (4.3) | 0.898 (0.015) | 68.2% (2.0) | 75.2% (3.3) | 58.7% (2.7) | 0.717 (0.021) |
17 | 76.4% (2.4) | 81.8% (3.2) | 66.5% (4.8) | 0.849 (0.017) | 68.2% (2.1) | 74.9% (2.1) | 59.4% (3.1) | 0.724 (0.023) |
18 | 72.3% (2.5) | 80.2% (2.4) | 58.3% (3.8) | 0.791 (0.015) | 76.3% (2.4) | 83.7% (3.2) | 68.7% (2.7) | 0.806 (0.022) |
19 | 79.5% (1.8) | 83.9% (1.8) | 71.7% (4.4) | 0.861 (0.014) | 73.5% (3.5) | 79.6% (3.6) | 65.7% (4.7) | 0.769 (0.017) |
20 | 86.3% (1.4) | 89.4% (1.9) | 80.5% (2.5) | 0.921 (0.007) | 65.8% (2.6) | 70.9% (2.2) | 59.2% (3.8) | 0.66 (0.022) |
The bold values Table 2 are means the best performance of two classification tasks.